Nina Schor, M.D., Ph.D., William H. Eilinger Chair of Pediatrics and the pediatrician-in-chief at UR Medicine’s Golisano Children’s Hospital, has been named a Fellow of the American Association for the Advancement of Science (AAAS), the world’s largest general scientific society.
AAAS, which will publish the announcement on Nov. 25 in its journal Science, selects Fellows based on their scientifically and socially distinguished efforts to advance science or its applications. Schor has spent much of her career investigating neuroblastoma — which is among the most common childhood cancers — and was recognized for “her distinguished contributions to developmental neuroscience and neuropharmacology, particularly using molecular neuroscientific discoveries to design innovative therapies for tumors of the developing nervous system.”
“Nina has helped lead advances in understanding the biology of these tumors, opening the door to precision medicine approaches to treat this common and often fatal childhood cancer,” said Jonathan W. Friedberg, M.D., M.M.Sc., director of Wilmot Cancer Institute. “Her work identifying new molecular targets and developing innovative therapies for neuroblastoma has had substantial impact, and we are fortunate to have someone like her in our community.”
Election as an AAAS Fellow is an honor bestowed upon AAAS members by their peers. The tradition of AAAS Fellows began in 1874, and members can be considered for the rank of Fellow if nominated by the steering groups of the Association’s 24 sections, by any three Fellows who are AAAS members, or by the AAAS chief executive officer. The organization has over 120,000 members; this year, 391 members were named as Fellows.
“It is always an extra special honor when one’s mentors and professional colleagues recognize one’s work,” said Schor. “To have been recognized in Neuroscience and Medical Sciences is truly humbling.”